Biotech Values

[investorgold2002]

Ernst & Young Entrepreneur Award is B.S

Wheeler should be rated based on how he delivers to shareholders.
I don't mind if he gets more shares so he is aligned with shareholders. If I had my ways I would have CEO's own more shares and options but less cash salary. I hate CEO's that don't deliver
and collect their million dollar salaries and add little value.
I am not saying wheeler is like that. But since he became CEO in 2006, not a lot has happened from business standpoint(besides lovenox which is huge)...Of course internally they are continuing to make progress on copaxone and building IP for FOB.
That's why I said, the FOB partnership is a real test for wheeler
I think he will deliver for shareholders

BTW
This Indian was also Ernst & Young Entrepreneur
Now he is a Fugitive

http://online.wsj.com/article/SB10001424052702303936704576398100826124240.html